144 related articles for article (PubMed ID: 38398589)
21. The reverse effect of X-ray irradiation on acquired gefitinib resistance in non-small cell lung cancer cell line NCI-H1975 in vitro.
Wang J; Wei H; Zhao B; Li M; Lv W; Lv L; Song B; Lv S
J Mol Histol; 2014 Dec; 45(6):641-52. PubMed ID: 25008024
[TBL] [Abstract][Full Text] [Related]
22. CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo.
Zhang K; Wang L; Wei A; Jia X; Liu X
Thorac Cancer; 2020 Jun; 11(6):1566-1577. PubMed ID: 32368855
[TBL] [Abstract][Full Text] [Related]
23. One-Pot Synthesis of Novel Thiazoles as Potential Anti-Cancer Agents.
Sayed AR; Gomha SM; Taher EA; Muhammad ZA; El-Seedi HR; Gaber HM; Ahmed MM
Drug Des Devel Ther; 2020; 14():1363-1375. PubMed ID: 32308369
[TBL] [Abstract][Full Text] [Related]
24. The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.
Shen L; Li Z; Shen S; Niu X; Yu Y; Li Z; Liao M; Chen Z; Lu S
Lung Cancer; 2012 Dec; 78(3):193-200. PubMed ID: 22985911
[TBL] [Abstract][Full Text] [Related]
25. Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines.
Salih MAF; Al-Hiari Y; Kasabri V; Darwish R; Abumansour H; Bourghli L; Al Alawi S; Albashiti R
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2507-2521. PubMed ID: 35901360
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
[TBL] [Abstract][Full Text] [Related]
27. Discovery of a Novel Potent Antitumor Molecule, P19G1, by Erlotinib Derivative Libraries Synthesized by Modular Click-Chemistry.
Cui Q; Song P; Ma T; Wang Z; Lu X; Shi Y; Zhang F; Lin G; Dong J; Zhang J
Technol Cancer Res Treat; 2022; 21():15330338221109649. PubMed ID: 36303409
[No Abstract] [Full Text] [Related]
28.
Hallaq T; Al-Hiari Y; Kasabri V; AlBashiti R; AlAlawi S; Telfah A
Anticancer Agents Med Chem; 2022; 22(19):3304-3321. PubMed ID: 35570520
[TBL] [Abstract][Full Text] [Related]
29. p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer.
Rho JK; Choi YJ; Ryoo BY; Na II; Yang SH; Kim CH; Lee JC
Cancer Res; 2007 Feb; 67(3):1163-9. PubMed ID: 17283151
[TBL] [Abstract][Full Text] [Related]
30. Design and Synthesis of New
Farghaly TA; Pashameah RA; Bayazeed A; Al-Soliemy AM; Alsaedi AMR; Harras MF
Med Chem; 2024; 20(1):63-77. PubMed ID: 37723960
[TBL] [Abstract][Full Text] [Related]
31. PPARĪ± agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARĪ±/AMPK/AKT/FoxO1 pathway.
Wang MS; Han QS; Jia ZR; Chen CS; Qiao C; Liu QQ; Zhang YM; Wang KW; Wang J; Xiao K; Ding XS
Acta Pharmacol Sin; 2022 Jan; 43(1):167-176. PubMed ID: 33772142
[TBL] [Abstract][Full Text] [Related]
32. FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer.
Sun C; Gao W; Liu J; Cheng H; Hao J
Respir Res; 2020 Aug; 21(1):210. PubMed ID: 32778129
[TBL] [Abstract][Full Text] [Related]
33. Design and Synthesis of Acridine-Triazole and Acridine-Thiadiazole Derivatives and Their Inhibitory Effect against Cancer Cells.
Huo L; Liu X; Jaiswal Y; Xu H; Chen R; Lu R; Nong Y; Williams L; Liang Y; Jia Z
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613504
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of new sarsasapogenin derivatives with antiproliferative and apoptotic effects in MCF-7 cells.
Wang W; Zhang Y; Yao G; Wang W; Shang X; Zhang Y; Wang X; Wang S; Song S
Steroids; 2018 Mar; 131():23-31. PubMed ID: 29337037
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
Khazir J; Hyder I; Gayatri JL; Prasad Yandrati L; Nalla N; Chasoo G; Mahajan A; Saxena AK; Alam MS; Qazi GN; Sampath Kumar HM
Eur J Med Chem; 2014 Jul; 82():255-62. PubMed ID: 24910974
[TBL] [Abstract][Full Text] [Related]
36. Design and Synthesis of Non-Covalent Imidazo[1,2-
Kumar M; Joshi G; Arora S; Singh T; Biswas S; Sharma N; Bhat ZR; Tikoo K; Singh S; Kumar R
Molecules; 2021 Mar; 26(5):. PubMed ID: 33803355
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological evaluation of a series of dianilinopyrimidines as EGFR inhibitors.
Yan L; Wang Q; Liu L; Le Y
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):832-843. PubMed ID: 35260020
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity.
Adly ME; Gedawy EM; El-Malah AA; El-Telbany FA
Anticancer Agents Med Chem; 2018; 18(5):747-756. PubMed ID: 29366427
[TBL] [Abstract][Full Text] [Related]
39. MiR-145 changes sensitivity of non-small cell lung cancer to gefitinib through targeting ADAM19.
Wang Y; Lian YM; Ge CY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5831-5839. PubMed ID: 31298334
[TBL] [Abstract][Full Text] [Related]
40. Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking.
Hassan RA; Hamed MIA; Abdou AM; El-Dash Y
Bioorg Chem; 2022 Aug; 125():105861. PubMed ID: 35569190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
